Skip to content

ALBUNEX Echocardiography Contrast Microspheres

by Molecular Biosystems, Inc.

PMA P900059

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P900059↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved 1 supplement NumberP900059 Date28 Aug 1995ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Full name
Albunex(R) Echocardiography Contrast Microspheres
Generic Name
Contrast media, ultrasound
PMA Number
FDA Product Code
MJS
Device Class
Class III
Advisory Committee
Radiology
FDA Decision
APPR Approved
PMA Supplement
S003 (Normal 180 Day Track)

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

ALBUNEX Echocardiography Contrast Microspheres are an ultrasound contrast agent designed to enhance the visualization of cardiac structures during echocardiography. The device consists of microspheres that improve the reflection of ultrasound waves, allowing for better delineation of blood flow and myocardial borders.

Supplied as a sterile, single-use product for intravenous administration in clinical echocardiography settings. The device is regulated under FDA PMA (P900059) and is not indicated for MRI use. Storage and handling specifications are defined by the manufacturer’s approved labeling and authorization documentation.

Other devices from Molecular Biosystems, Inc.

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary function of ALBUNEX Echocardiography Contrast Microspheres?

    ALBUNEX Echocardiography Contrast Microspheres enhance ultrasound imaging by increasing the echogenicity of blood, which improves the visualization of cardiac chambers and blood flow during echocardiography procedures.

  • Is ALBUNEX Echocardiography Contrast Microspheres a single-use or reusable device?

    ALBUNEX Echocardiography Contrast Microspheres are supplied as a sterile, single-use product intended for intravenous administration and are not designed for reuse.

  • What regulatory authorization does ALBUNEX Echocardiography Contrast Microspheres have?

    ALBUNEX Echocardiography Contrast Microspheres received FDA Premarket Approval (PMA) under application number P900059, which was approved on August 28, 1995.